Cargando…

The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD

Vanadium is a well-known essential trace element, which usually exists in oxidation states in the form of a vanadate cation intracellularly. The pharmacological study of vanadium began with the discovery of its unexpected inhibitory effect on ATPase. Thereafter, its protective effects on β cells and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Jinyi, He, Zhijun, You, Guanying, Liu, Qiong, Li, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453015/
https://www.ncbi.nlm.nih.gov/pubmed/37623221
http://dx.doi.org/10.3390/cimb45080402
_version_ 1785095816024686592
author Yao, Jinyi
He, Zhijun
You, Guanying
Liu, Qiong
Li, Nan
author_facet Yao, Jinyi
He, Zhijun
You, Guanying
Liu, Qiong
Li, Nan
author_sort Yao, Jinyi
collection PubMed
description Vanadium is a well-known essential trace element, which usually exists in oxidation states in the form of a vanadate cation intracellularly. The pharmacological study of vanadium began with the discovery of its unexpected inhibitory effect on ATPase. Thereafter, its protective effects on β cells and its ability in glucose metabolism regulation were observed from the vanadium compound, leading to the application of vanadium compounds in clinical trials for curing diabetes. Alzheimer’s disease (AD) is the most common dementia disease in elderly people. However, there are still no efficient agents for treating AD safely to date. This is mainly because of the complexity of the pathology, which is characterized by senile plaques composed of the amyloid-beta (Aβ) protein in the parenchyma of the brain and the neurofibrillary tangles (NFTs), which are derived from the hyperphosphorylated tau protein in the neurocyte, along with mitochondrial damage, and eventually the central nervous system (CNS) atrophy. AD was also illustrated as type-3 diabetes because of the observations of insulin deficiency and the high level of glucose in cerebrospinal fluid (CSF), as well as the impaired insulin signaling in the brain. In this review, we summarize the advances in applicating the vanadium compound to AD treatment in experimental research and point out the limitations of the current study using vanadium compounds in AD treatment. We hope this will help future studies in this field.
format Online
Article
Text
id pubmed-10453015
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104530152023-08-26 The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD Yao, Jinyi He, Zhijun You, Guanying Liu, Qiong Li, Nan Curr Issues Mol Biol Review Vanadium is a well-known essential trace element, which usually exists in oxidation states in the form of a vanadate cation intracellularly. The pharmacological study of vanadium began with the discovery of its unexpected inhibitory effect on ATPase. Thereafter, its protective effects on β cells and its ability in glucose metabolism regulation were observed from the vanadium compound, leading to the application of vanadium compounds in clinical trials for curing diabetes. Alzheimer’s disease (AD) is the most common dementia disease in elderly people. However, there are still no efficient agents for treating AD safely to date. This is mainly because of the complexity of the pathology, which is characterized by senile plaques composed of the amyloid-beta (Aβ) protein in the parenchyma of the brain and the neurofibrillary tangles (NFTs), which are derived from the hyperphosphorylated tau protein in the neurocyte, along with mitochondrial damage, and eventually the central nervous system (CNS) atrophy. AD was also illustrated as type-3 diabetes because of the observations of insulin deficiency and the high level of glucose in cerebrospinal fluid (CSF), as well as the impaired insulin signaling in the brain. In this review, we summarize the advances in applicating the vanadium compound to AD treatment in experimental research and point out the limitations of the current study using vanadium compounds in AD treatment. We hope this will help future studies in this field. MDPI 2023-07-31 /pmc/articles/PMC10453015/ /pubmed/37623221 http://dx.doi.org/10.3390/cimb45080402 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Yao, Jinyi
He, Zhijun
You, Guanying
Liu, Qiong
Li, Nan
The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD
title The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD
title_full The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD
title_fullStr The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD
title_full_unstemmed The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD
title_short The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD
title_sort deficits of insulin signal in alzheimer’s disease and the mechanisms of vanadium compounds in curing ad
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453015/
https://www.ncbi.nlm.nih.gov/pubmed/37623221
http://dx.doi.org/10.3390/cimb45080402
work_keys_str_mv AT yaojinyi thedeficitsofinsulinsignalinalzheimersdiseaseandthemechanismsofvanadiumcompoundsincuringad
AT hezhijun thedeficitsofinsulinsignalinalzheimersdiseaseandthemechanismsofvanadiumcompoundsincuringad
AT youguanying thedeficitsofinsulinsignalinalzheimersdiseaseandthemechanismsofvanadiumcompoundsincuringad
AT liuqiong thedeficitsofinsulinsignalinalzheimersdiseaseandthemechanismsofvanadiumcompoundsincuringad
AT linan thedeficitsofinsulinsignalinalzheimersdiseaseandthemechanismsofvanadiumcompoundsincuringad
AT yaojinyi deficitsofinsulinsignalinalzheimersdiseaseandthemechanismsofvanadiumcompoundsincuringad
AT hezhijun deficitsofinsulinsignalinalzheimersdiseaseandthemechanismsofvanadiumcompoundsincuringad
AT youguanying deficitsofinsulinsignalinalzheimersdiseaseandthemechanismsofvanadiumcompoundsincuringad
AT liuqiong deficitsofinsulinsignalinalzheimersdiseaseandthemechanismsofvanadiumcompoundsincuringad
AT linan deficitsofinsulinsignalinalzheimersdiseaseandthemechanismsofvanadiumcompoundsincuringad